Concorde Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $521K | Sell |
|
|||||
|
2024
Q4 | $517K | Sell |
|
|||||
|
2024
Q3 | $613K | Sell |
|
|||||
|
2024
Q2 | $540K | Buy |
|
|||||
|
2024
Q1 | $559K | Buy |
|
|||||
|
2023
Q4 | $443K | Hold |
|
|||||
|
2023
Q3 | $426K | Sell |
|
|||||
|
2023
Q2 | $3.13M | Sell |
|
|||||
|
2023
Q1 | $4.69M | Buy |
|
|||||
|
2022
Q4 | $289K | Buy |
|
|||||
|
2022
Q3 | $238K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $317K | Buy |
|
|||||
|
2021
Q4 | $214K | Sell |
|
|||||
|
2021
Q3 | $295K | Buy |
|
|||||
|
2021
Q2 | $230K | Sell |
|
|||||
|
2021
Q1 | $1.11M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $209K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $250K | Sell |
|
|||||
|
2019
Q3 | $239K | Sell |
|
|||||
|
2019
Q2 | $293K | Buy |
|
|||||
|
2019
Q1 | $296K | Sell |
|
|||||
|
2018
Q4 | $315K | Buy |
|
|||||
|
2018
Q3 | $288K | Buy |
|
|||||
|
2018
Q2 | $203K | Sell |
|
|||||
|
2018
Q1 | $212K | Sell |
|
|||||
|
2017
Q4 | $223K | Buy |
|
|||||
|
2017
Q3 | $244K | Sell |
|
|||||
|
2017
Q2 | $301K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $255K | Sell |
|
|||||
|
2016
Q3 | $892K | Buy |
|